跳至主要内容
临床试验/JPRN-UMIN000052109
JPRN-UMIN000052109尚未招募Unknown

The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P) - The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P)

Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)0 个研究点目标入组 500 人开始时间: 2023年9月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with preoperative chemotherapy (neoadjuvant chemotherapy or neoadjuvant chemo-radiotherapy) 2. Patients who have not undergone R0 or R1 resection 3. Histological types other than pancreatic ductal cancer 4. Patients who have not been treated by postoperative adjuvant chemotherapy 5. Patients who have opted out and have been refused access to medical information by research subjects or their familiy

研究者

发起方
Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)

相似试验